FABTECH Fabtech Technologies Q3 FY26 results (Oct–Dec 2025) and concall
Fabtech Technologies Limited reported Q3 FY26 results impacted by timing-related revenue deferrals of approximately 20.3 crores to Q4 FY26, leading to a temporary dip in top and bottom lines. Despite this, the company maintains a strong order book of 926 crores as of January 31, 2026, and a healthy pipeline of $455 million. Management reiterated full-year FY26 guidance of ₹380-400 crores revenue and ₹39-41 crores PAT, targeting 30-40% YoY growth and 9-11% PAT margins, driven by strategic acquisitions and focus on emerging pharmaceutical markets.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue down 26.6%, net profit down 75.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 50 | 64 | 97 | 30 | 81 +62% | 47 −27% |
| EBITDA | 8 | 7 | 15 | -9 | 23 +175% | -5 −168% |
| Net profit | 8 | 6 | 12 | -9 | 21 +157% | 1 −75% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
